Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ B<0lif|
!PQ@"L)p
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© cFH,fj
d}WAP m
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ;zh|*F>
lI&0
V5
1.Co-stimulators (or co-stimulating molecules) F]~`57
uvm=i .
2.NK-kB ^KlMBKWyB
v,2{Vr
3.Immunoglobulin superfamily {v2Q7ZO-
nQ/El&{
4.antigen-presenting cell (APC) .m+KXlP
ggbew6L$Z
5.death domain ^WUF3Q**OU
J#JZ^59lOS
6.CCR and CXCR %=_Iq\lC
5[;p<GqGN
7.Lectin (or mitogen) &&t4G }*
&z,w0FOre
8.Clusters of differentiation, CD) M%6{A+(
B8C"i%8V)
9.B7 family 1?mQ
fW@G
c%v%U &
10.Cytotoxic T lymphocyte, CTL)
LqU]&AAh
Z*kg= hs^
11.IL-15 and IL-15 receptor (IL-15R) JLs7[W)O
FIW*Nr
12.MHC restriction Ag}>gbz~G
W;,Jte<'Nm
13.Affinity-chromatography }
Z%*gfp
<5q:mG88
14.Cyctosprin A, CsA U3p=H^MB.
x?f3XEA_
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ?p6+?\H
x'n J
_0
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© PcJ,Y\"[
m"jqHGFV
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 %*:-4K
ud!iy
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ lq+FH&
,AACE7%l
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ 8 =J6{{E
/Nb&e
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© H|
Q)Tp Lk
v#=-
ÃâÒßѧרҵ£º R.+QK6B&
;M\H#%G.
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ QH#|R92:
qnruatA
Ïû»¯ÄÚ¿Æ£º Z2hRTJJ[A
(CO8t~J=
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ;l+3l
ez
6z!?U:bT
ѪҺ²¡Ñ§×¨Òµ£º LlX 7g_!
gb8nST$r
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿